Clinical medicine (London, England)
-
Retraction Of Publication
WITHDRAWN: Use of proton pump inhibitors (PPI) in patients with acute coronary syndrome (ACS) receiving dual-antiplatelet therapy (DAPT).
: This article has been withdrawn: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal). This article has been withdrawn at the request of the authors, editor and publisher. ⋯ This error bears no reflection on the article or its authors. The publisher apologizes to the authors and the readers for this unfortunate error.
-
Huntington's disease (HD) usually manifests in adulthood and is characterised by progressive neurodegeneration in the brain that causes worsening involuntary movements, mental health and cognition over many years. Depression, anxiety and apathy are common. ⋯ Progression of HD is usually slow, and so acute deteriorations often indicate another problem, such as intercurrent infections, constipation, urinary retention, gastro-oesophageal reflux disease or poor dentition. In this review we outline common presentations in HD patients, both acute and chronic, consider therapeutic options and discuss specific considerations in advanced HD.